Tag: genomics
-
Addiction Biotech Using Crowdfunding for Investments
A start-up enterprise developing treatments for drug and alcohol addiction is raising investment capital with a direct pitch to small investors through a crowdfunding platform.
-
Eye Disease Gene-Therapy Biotech Adds Venture Funds
A biotechnology company designing treatments for inherited eye diseases with Crispr gene editing is raising €75 million in venture financing.
-
Cell, mRNA Therapy Biotech Raises $165M in Early Funds
A new company, founded by university medical researchers, is developing cell therapies engineered with messenger RNA or mRNA to work inside the body.
-
Exec. Order Aims to Boost U.S. Biotech, Manufacturing
An executive order issued by President Joe Biden yesterday seeks to make biotechnology and biomanufacturing a centerpiece of the American economy.
-
Gut Microbes Shown to Detect Colorectal Cancer
An analysis of gut bacteria and blood samples from patients indicates changes in the microbiome can provide early warnings for colorectal cancer.
-
Trial to Assess Multi-Factor Blood Test for Cancer
A clinical trial is set to begin that evaluates genomic and related data from routine blood tests to screen for cancer in real-world settings.
-
Venture to Build Cell, Gene Therapy Businesses
A joint venture with business development and bio-manufacturing companies aims to build new cell and gene therapy businesses to advance treatments from Mayo Clinic labs.
-
Cannabinoid Synthesis Process Licensed to Spin-Off Company
A genetic technology for synthesizing cannabinoid compounds without cannabis cells was licensed to a company spun-off from the lab that developed the process.
-
AI Recreates Tumor Environment for Precision Cancer Care
A bioinformatics company designed an algorithm that digitally recreates the support network for tumors from RNA sequences, to guide precise treatments for cancer patients.
-
Synthetic Bio Chemicals Start-Up Gains $5M in Early Funds
A new enterprise using digital and synthetic biology to create sustainable chemicals at industrial scale is raising $5 million in pre-seed round funds.